| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/27/2009 | WO2009105167A2 Selective poly-n-substituted glycine antibiotics |
| 08/27/2009 | WO2009104988A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 08/27/2009 | WO2009104963A1 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 08/27/2009 | WO2009104911A2 Uses as agents for prophylaxis or treatment of cervical cancer |
| 08/27/2009 | WO2009104706A1 Microparticles and pharmaceutical compositions thereof |
| 08/27/2009 | WO2009104649A1 Synthetic glycolipid-containing liposomes |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104001A2 Oligopeptidic compounds and uses thereof |
| 08/27/2009 | WO2009103977A1 Compounds and methods for the prevention or treatment of restenosis |
| 08/27/2009 | WO2009103898A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/27/2009 | WO2009103826A1 System for producing multimeric peptides and proteins and use thereof |
| 08/27/2009 | WO2009103821A2 Means for treating virus infections |
| 08/27/2009 | WO2009103816A1 Method for treatment of photosensitivity and phototoxicity |
| 08/27/2009 | WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases |
| 08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| 08/27/2009 | WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009103160A1 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 08/27/2009 | WO2009103105A2 Mimotope |
| 08/27/2009 | WO2009086296A3 Counter-pressure filtration of proteins |
| 08/27/2009 | WO2009083663A3 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 08/27/2009 | WO2009083249A3 Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity |
| 08/27/2009 | WO2009080823A3 Nerve growth factor conjugates and uses thereof |
| 08/27/2009 | WO2009078977A3 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/27/2009 | WO2009073569A3 Protein formulations and methods of making same |
| 08/27/2009 | WO2009073544A3 Methods for treating a disorder by regulating gprc6a |
| 08/27/2009 | WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 08/27/2009 | WO2009070564A3 Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
| 08/27/2009 | WO2009046453A9 Use of neuregulin-1 in reducing brain damage |
| 08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
| 08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/27/2009 | WO2009033668A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2008133749A3 Antimicrobial agents from microbial genomes |
| 08/27/2009 | WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 08/27/2009 | WO2007135492A3 Methods for making a multicomponent hemostatic dressing |
| 08/27/2009 | WO2007044069A3 Pth formulations and methods of use |
| 08/27/2009 | WO2007011859A3 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 08/27/2009 | WO2004040000A9 G protein coupled receptors and uses thereof |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090217391 T1r3 a novel taste receptor |
| 08/27/2009 | US20090216317 Delivery of Highly Lipophilic Agents Via Medical Devices |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215984 Conversion of apoptotic proteins |
| 08/27/2009 | US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 08/27/2009 | US20090215981 Glp-1 Pegylated Compounds |
| 08/27/2009 | US20090215856 Methods for monitoring IL-18 |
| 08/27/2009 | US20090215703 PAR-2 Agonist |
| 08/27/2009 | US20090215702 Uv-Induced Dermatitis Inhibitor and Atopic Dermatitis Inhibitor |
| 08/27/2009 | US20090215701 Enhancement of Iron Chelation Therapy |
| 08/27/2009 | US20090215700 amino acid substitutes provide blood stability, solubility, pharmacokinetics, supression of cancer metastasis; gelation tendency is reduced; gonadotropic hormone secretion is suppressed; Ac-D-Tyr-Hyp-Asn-Thr-Cha-Gly-Ala(cPr)-Arg(Me)-Trp-NH2 |
| 08/27/2009 | US20090215699 Pharmaceutically Active Antiviral Peptides |
| 08/27/2009 | US20090215698 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/27/2009 | US20090215697 Composition for the treatment of atherosclerosis |
| 08/27/2009 | US20090215696 Toxoplasma gondii Oocyst Protein |
| 08/27/2009 | US20090215695 Regulation of cytokine synthesis and release |
| 08/27/2009 | US20090215694 Lyophilized Formulations of Exendins and Exendin Agonist Analogs |
| 08/27/2009 | US20090215693 Methods for increasing hyaluronic acid levels and improving moisture retention in tissue |
| 08/27/2009 | US20090215692 Compositions and methods to prevent cancer with cupredoxins |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215690 Dickkopf1 (Dkk1) is a dual function protein demonstrates a mechanism for the coordination of cell migration and antagonism of Wnt/ beta -catenin signaling during developmental and pathological processes; finding therapeutic anticarcinogenic agent for breast cancer |
| 08/27/2009 | US20090215689 Fgf2-binding peptides and uses thereof |
| 08/27/2009 | US20090215688 GLP-I Agonist And Cardiovascular Complications |
| 08/27/2009 | US20090215687 Compounds for Enhancing Hypoxia Inducible Factor Activity and Methods of Use |
| 08/27/2009 | US20090215686 Nk1-based polypeptides and related methods |
| 08/27/2009 | US20090215685 Methods for inhibiting hair depigmentation and hair loss |
| 08/27/2009 | US20090215684 Use of BPI Protein for Treatment of Diseases |
| 08/27/2009 | US20090215683 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 08/27/2009 | US20090215682 Modified PYY (3-36) Peptides and Their Effects on Feeding Behaviour |
| 08/27/2009 | US20090215681 Methods of Diagnosis and Treatment of Metabolic Disorders |
| 08/27/2009 | US20090215680 Inhibitor peptides |
| 08/27/2009 | US20090215679 Disease-associated proteins |
| 08/27/2009 | US20090215678 Preventing Vertical Endoparasite Infections |
| 08/27/2009 | US20090215677 Polymyxin derivatives and uses thereof |
| 08/27/2009 | US20090215676 Method of treatment |
| 08/27/2009 | US20090215675 Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| 08/27/2009 | US20090215674 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 08/27/2009 | US20090215673 a solution of the glycopeptide derivatives containing phosphono group which acts as antibacterial agent, a polystyrene modified with divinylbenzene bead and an acidified aqueous solution ( acetic acid or HCl) of polar solvent e.g. methanol, acetonitrile, ethanol; for purification by resin chromatography |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215671 Compositions And Methods For Treatment of Neural Disorders Using Transforming Growth Factor-Beta Superfamily Proteins And Their Antagonists |
| 08/27/2009 | US20090215670 Site specific pegylated hemoglobin, method of preparing same, and uses thereof |
| 08/27/2009 | US20090215669 Compositions and methods for treatment of diabetes |
| 08/27/2009 | US20090215668 Methods of making and uses of compositions that modulate intronic region-encoded protein function |
| 08/27/2009 | US20090215667 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants |
| 08/27/2009 | US20090215666 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 08/27/2009 | US20090215665 Compositions and methods for promoting wound healing and tissue regeneration |
| 08/27/2009 | US20090215170 Plexin family-like polypeptide, DNA encoding the same and uses thereof |
| 08/27/2009 | US20090215164 Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases |
| 08/27/2009 | US20090215151 Two-Step Immunization Procedure Against Chlamydia Infection |
| 08/27/2009 | US20090215145 Method for controlling nad(p)/nad(p)h ratio by oxidoreductase |
| 08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 08/27/2009 | US20090215009 Medical material, artificial tooth root, and method of producing medical material |
| 08/27/2009 | US20090214680 Weight Loss Composition |
| 08/27/2009 | US20090214669 Combination anticancer therapy and pharmaceutical compositions therefore |
| 08/27/2009 | US20090214663 Virus coated nanoparticles and uses thereof |
| 08/27/2009 | US20090214657 Orally Absorbed Pharmaceutical Formulation and Method of Administration |
| 08/27/2009 | US20090214653 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 08/27/2009 | US20090214652 Soft tissue implants and anti-scarring agents |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |